Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy
Theravance Biopharma, Inc. (
NASDAQ: TBPH) today announced the launch of “Power in the Periphery,” a new disease education campaign for healthcare professionals (HCPs) to raise awareness and deepen scientific understanding of the pathophysiology underlying neurogenic orthostatic hypotension (nOH) associated with Multiple System Atrophy (MSA). The initiative was introduced at the International Congress of Parkinson’s Disease and Movement Disorders® (MDS), held in Honolulu, Hawaii, October 5–9, 2025.
